Nutex Health, Inc.·4

May 10, 3:52 PM ET

Montgomery Pamela W. 4

4 · Nutex Health, Inc. · Filed May 10, 2023

Insider Transaction Report

Form 4
Period: 2023-04-01
Montgomery Pamela W.
Chief Legal Officer-Healthcare
Transactions
  • Exercise/Conversion

    Common Stock

    2023-04-01+16,50216,502 total
  • Award

    Restricted Stock Unit

    2023-04-01+49,50549,505 total
    Common Stock (49,505 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    2023-04-0116,50233,003 total
    Common Stock (16,502 underlying)
Footnotes (2)
  • [F1]Each RSU represents a contingent right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.
  • [F2]Pursuant to the Restricted Stock Unit Agreement by and between the issuer and Ms. Montgomery, dated April 1, 2023, the 49,505 RSUs granted to Ms. Montgomery will vest in three equal installments, with the initial 1/3 immediately vested on April 1, 2023, and the remaining RSUs vesting 1/3 each on March 1, 2024 and March 1, 2025.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES